At the surface level, this astonishingly opposes the notion that CD8+ T lymphocytes target cells with surface expression of MHC class I protein, and that its subsequent downregulation can be exploited as a strategy for immune evasion by a malignant tumour. The gene discussed is CD8A; the disease is neoplasm.